We are live on ! Find out more
PP

Paloma Partners Portfolio holdings

AUM $510M
1-Year Est. Return 286.05%
This Fund
S&P 500
This Quarter Est. Return
+3.59%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$10.2B
AUM Growth
+$2.21B
Cap. Flow
+$1.91B
Cap. Flow %
18.7%
Top 10 Hldgs %
42.15%
Holding
2,326
New
523
Increased
761
Reduced
552
Closed
381

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$88.6M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$55.2M
3
AMZN icon
Amazon
AMZN
+$50.7M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$50.4M
5
AAPL icon
Apple
AAPL
+$27.4M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 4.46%
2 Industrials 3.74%
3 Financials 3.69%
4 Healthcare 3.55%
5 Technology 3.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RTX icon
1226
CALL
RTX Corp
RTX
$295B
$877K 0.01%
12,712
-29,555
-70% -$1.96M
RTX icon
1227
PUT
RTX Corp
RTX
$295B
$877K 0.01%
12,712
-29,555
-70% -$1.96M
SPWR
1228
DELISTED
SunPower Corporation Common Stock
SPWR
$877K 0.01%
202,593
+80,433
+66% +$393K
CSRA
1229
DELISTED
CSRA Inc.
CSRA
$876K 0.01%
+27,500
New +$804K
VSH icon
1230
Vishay Intertechnology
VSH
$5.02B
$874K 0.01%
53,919
+2,209
+4% +$32.9K
TAP icon
1231
Molson Coors Class B
TAP
$7.97B
$872K 0.01%
8,958
-78,645
-90% -$8.02M
UHS icon
1232
CALL
Universal Health Services
UHS
$10.1B
$872K 0.01%
8,200
+1,600
+24% +$189K
UHS icon
1233
PUT
Universal Health Services
UHS
$10.1B
$872K 0.01%
8,200
+1,600
+24% +$189K
DEI icon
1234
Douglas Emmett
DEI
$2.01B
$871K 0.01%
23,806
-13,369
-36% -$483K
ELV icon
1235
Elevance Health
ELV
$83.7B
$865K 0.01%
6,014
-3,136
-34% -$420K
FHI icon
1236
Federated Hermes
FHI
$4.59B
$865K 0.01%
30,613
+3,367
+12% +$93.3K
LITE icon
1237
Lumentum
LITE
$50.7B
$865K 0.01%
22,380
-11,277
-34% -$449K
UAA icon
1238
Under Armour
UAA
$3.04B
$865K 0.01%
+29,752
New +$976K
BG icon
1239
Bunge Global
BG
$22.8B
$861K 0.01%
11,929
-54,308
-82% -$3.62M
GCO icon
1240
Genesco
GCO
$432M
$861K 0.01%
+13,861
New +$846K
MEI icon
1241
Methode Electronics
MEI
$525M
$861K 0.01%
20,815
+10,686
+105% +$392K
NEE icon
1242
NextEra Energy
NEE
$186B
$860K 0.01%
28,800
-26,500
-48% -$792K
MSGN
1243
DELISTED
MSG Networks Inc.
MSGN
$856K 0.01%
39,806
+13,269
+50% +$264K
NVDA icon
1244
PUT
NVIDIA
NVDA
$4.77T
$854K 0.01%
320,000
-280,000
-47% -$585K
GOOG icon
1245
Alphabet (Google) Class C
GOOG
$4.07T
$849K 0.01%
22,000
-660
-3% -$25.7K
VNDA icon
1246
Vanda Pharmaceuticals
VNDA
$310M
$843K 0.01%
52,823
+10,190
+24% +$164K
HBAN icon
1247
Huntington Bancshares
HBAN
$35B
$841K 0.01%
+63,587
New +$741K
HXL icon
1248
Hexcel
HXL
$8.3B
$840K 0.01%
+16,333
New +$785K
MDR
1249
DELISTED
McDermott International
MDR
$839K 0.01%
+37,828
New +$705K
CRZO
1250
DELISTED
Carrizo Oil & Gas Inc
CRZO
$839K 0.01%
+22,460
New +$867K

Similar funds

Paloma Partners's Q4 2016 Portfolio in Review

As of Q4 2016, Paloma Partners held 2,326 positions worth $10.2B, up 28% from $7.99B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Paloma Partners deployed $1.91B of net new capital in Q4 2016, opening 523 new positions and adding to 761 existing holdings. Its largest new stake was NXP Semiconductors: 253,000 shares worth $24.8M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 4.5% of assets, up from 3.4% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was KLA, an estimated $30.4M trimmed.

  • Paloma Partners's largest Q4 2016 buy was NXP Semiconductors: 253,000 shares worth $24.8M.
  • Paloma Partners added most to Biogen in Q4 2016, an estimated $88.6M increase.
  • Paloma Partners's biggest Q4 2016 reduction was KLA, cutting an estimated $30.4M.
  • Paloma Partners fully exited St Jude Medical in Q4 2016, selling an estimated $13.5M.
  • Paloma Partners's ten largest holdings make up 42% of its $10.2B portfolio in Q4 2016.
  • Paloma Partners opened 523 new positions and closed 381 in Q4 2016.
  • Paloma Partners's portfolio value rose 28% quarter-over-quarter to $10.2B.

Based on Paloma Partners's 13F filing for Q4 2016, filed 14 Feb 2017.